BDBM293980 (2S)-3-((4-(5-((4-(1-(1H- Tetrazol-5-yl)pent-3-yn-2- yl)phenoxy)methyl)benzo[b] thiophen-3-yl)-3- methylphenoxy)methyl)-3- methylthietane 1,1-dioxide::US10106553, Compound 12

SMILES CC#C[C@@H](Cc1nnn[nH]1)c1ccc(OCc2ccc3scc(-c4ccc(OCC5(C)CS(=O)(=O)C5)cc4C)c3c2)cc1

InChI Key InChIKey=NRDOHRGETHFOHC-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 293980   

TargetFree fatty acid receptor 1(Human)
Janssen Pharmaceutica

US Patent
LigandChemical structure of BindingDB Monomer ID 293980BDBM293980(US10106553, Compound 12 | (2S)-3-((4-(5-((4-(1-(1H...)
Affinity DataEC50:  28nMT: 2°CAssay Description:Compounds were tested in a calcium flux assay using transfected HEK293 cells stably expressing either human GPR40 or rat GPR40. Human GPR40 expressin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent